Each year, our trends report is about more than forecasting what’s next in wellness – it’s about our customers,” Fresh Thyme ...
AbbVie today announced the U.S. Food and Drug Administration (FDA) approval of a supplemental new drug application (sNDA) that updates the indication statement for RINVOQ® (upadacitinib) for the ...
Featuring Over 3,200 Global Exhibitors; Leading Chinese Mainland Tech Giants Showcase Cutting-edge AI and Robotics Solutions ...
8h
LEQEMBI® IQLIK™(lecanemab-irmb) Subcutaneous Autoinjector Named to TIME's "Best Inventions of 2025"
Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Headquarters: Cambridge, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback